In a bid to curb high mortality rate resulting from cancer complications, Kleef and Helixor Pharmaceuticals Nigeria Limited, in partnership with the ministry of health has developed a therapy used as supportive treatment to alleviate the basic side effects of the disease by providing an alternative to the conventional approach treatment patients undergo from using chemotherapy and radiotherapy treatments.
Chairman, Dr Cliff Ogbede said the initiative became paramount to curtail the high number of Nigerians who travel out to seek medical help as well as to create easy access for the down trodden who may not be buoyant enough to travel out for medical treatment, thus the need to bring it home and to ensure that the drug is accessible and affordable to everybody.
Dr Ozurigbo Chimobi, during his presentation averred that the drugs target all kinds of cancer depending on the organ region, adding that the cancer treatment is approached from any perspective, adding that the type of cancer determines what drugs should be used for the patient.
He said the medical products which are manufactured in Germany is coming into Africa, and Nigeria for the first time, adding that it is NAFDAC certified, and will be used as a palliative approach together with the conventional therapies done for cancer patients. Chimobi stressed that it has been proven with high efficacy and has been used very well in the G-7 countries, comprising of US, Canada, Switzerland, Russia, South Korea, and Japan.
In the same vain, he advised that it is important to embrace preventive health care measures that will protect our body from cancer, especially, from electromagnetic radiation from phones which affects human organism. He explained that for every call made a thousand cells die, but that it’s medical team will soon launch anti-radiative stickers which will be put in phones to stop proliferation of cells which degenerate into tumor and causes cancer.